Anzeige
Mehr »
Login
Donnerstag, 13.03.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Aktie des Tages: Die nächste Chance auf einen potentiellen Multi-Tenbagger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol: N/A
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.02.CV Sciences, Inc. - 8-K, Current Report-
11.02.CV Sciences, Inc. - 8-K, Current Report-
05.02.CV Sciences, Inc.: CV Sciences Unveils New Aura Collection THC Fizz Tablets141The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025...
► Artikel lesen
22.11.24Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know9
21.11.24CV Sciences to acquire Extract Labs in strategic expansion4
21.11.24CV Sciences enters into agreement to acquire Extract Labs2
CV SCIENCES Aktie jetzt für 0€ handeln
21.11.24CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs112SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
21.11.24CV Sciences, Inc. - 8-K, Current Report-
14.11.24CV Sciences Q3: Revenue Stable Amid New Launches, Financing1
14.11.24CV Sciences, Inc. - 10-Q, Quarterly Report-
14.11.24CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M1
14.11.24CV Sciences, Inc. Reports Third Quarter 2024 Financial Results128SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
14.11.24CV Sciences, Inc. - 8-K, Current Report-
13.08.24CV Sciences, Inc. Reports Second Quarter 2024 Financial Results293SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
14.05.24CV Sciences, Inc. Reports First Quarter 2024 Financial Results200SAN DIEGO, May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
28.03.24CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results252SAN DIEGO, March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1